> ## Content Index
> Fetch the complete content index at: https://elonmuscular.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Tirzepatide
- URL: https://elonmuscular.com/tirzepatide/
- Published: 2026-08-15T10:06:45.000Z
- Updated: 2026-10-12T07:42:57.000Z
- Description: If you're carrying real weight, take tirzepatide and train while you're on it.
- Author: Elon Muscular
- Tags: Metabolism, Food, Professional

[The library](https://elonmuscular.com/library/) / Metabolism

# Tirzepatide

Around 20% of body weight comes off over 72 weeks at the top doses.

Also called Mounjaro, Zepbound, LY3298176

An FDA-approved medicine

Who it's forAny man with real weight to lose who's been white-knuckling diets for years.

[Start](#dd-start)[Studies](#dd-studies)

The call

If you're carrying real weight, take tirzepatide and train while you're on it.

On this page

[Start today](#dd-start)[Why it works](#dd-why)[The doses](#dd-doses)[What to watch](#dd-watch)[Where it fits](#dd-fits)[What people say](#dd-say)[Questions](#dd-faq)[The studies](#dd-studies)[Words on this page](#dd-words)

## Start today

1. Book a real prescriber this week, and lift three days a week from your first shot.

## Why it works

Tirzepatide is semaglutide's stronger successor. One molecule hits two gut-hormone receptors instead of one. Under the names Mounjaro and Zepbound, it posts the biggest weight-loss numbers of any approved drug.

Hits GLP-1 and GIP receptors together: two hormone levers, one molecule.

In head-to-head trials, hitting both receptors beats hitting one on both glucose and weight.

## The doses the studies used

| Study / Context                                  | Route        | Dose    | Duration                    |
| ------------------------------------------------ | ------------ | ------- | --------------------------- |
| Standard Dose Escalation (FDA-Approved Labeling) | Subcutaneous | 2.5 mg  | Weeks 1-4 (initiation dose) |
| Standard Dose Escalation (FDA-Approved Labeling) | Subcutaneous | 5 mg    | Weeks 5-8                   |
| Standard Dose Escalation (FDA-Approved Labeling) | Subcutaneous | 7.5 mg  | Weeks 9-12                  |
| Standard Dose Escalation (FDA-Approved Labeling) | Subcutaneous | 10 mg   | Weeks 13-16                 |
| Standard Dose Escalation (FDA-Approved Labeling) | Subcutaneous | 12.5 mg | Weeks 17-20                 |
| Standard Dose Escalation (FDA-Approved Labeling) | Subcutaneous | 15 mg   | Week 21 onward              |

## What to watch

Who should avoid

Same exclusions as the class: medullary thyroid carcinoma or MEN2 history, prior pancreatitis, pregnancy.

Stop signals

Severe abdominal pain, thyroid-area symptoms, dehydration from persistent vomiting, gallbladder pain.

The common tax

Early gut effects (nausea, constipation, diarrhea), mostly while the dose is stepped up.

## Where it fits

Tirzepatide is a move in 10 protocols. Each one opens the plan it sits in.

- [Use Weight-Loss Medicine Right](https://elonmuscular.com/protocol-weight-medicine/)
- [Keep the Fat Off](https://elonmuscular.com/protocol-weight-regain/)
- [Keep the Fat Off After GLP-1](https://elonmuscular.com/protocol-after-glp1/)
- [Lose Fat and Build Muscle](https://elonmuscular.com/protocol-body-recomp/)
- [Earn Your Abs](https://elonmuscular.com/protocol-visible-abs/)
- [Bring Down Your Blood Sugar](https://elonmuscular.com/protocol-blood-sugar/)
- [Lose Fat](https://elonmuscular.com/protocol-diet-fat-loss-and-metabolism/)
- [Fix Your Sleep Apnea](https://elonmuscular.com/protocol-sleep-apnoea/)
- [Keep Your Muscle on GLP-1](https://elonmuscular.com/protocol-glp1-muscle/)
- [Stack TRT Right](https://elonmuscular.com/protocol-testosterone-trt-plus/)

New Heroes

The full library. Elon answers every weekday.

[Join New Heroes.](https://elonmuscular.com/join/)

Cancel anytime.

## What people say

Here is what doctors, influencers and men online say about Tirzepatide, word for word.

### Experts

Clinicians, authorities

- > “reported a reduction in bodyweight of up to 20.9% (treatment policy estimand) after 72 weeks of treatment with maximum dose of tirzepatide (15 mg s.c. once weekly).”  
>  
> Patient Preference and Adherence (journal review, PMC) · up to 20.9% body weight reduction at 72 weeks on 15 mg
- > “Those randomized to receive the highest approved dosage of Zepbound (15 mg once weekly) lost on average 18% of their body weight compared to those randomized to placebo.”  
>  
> U.S. Food and Drug Administration · 18% average loss at 15 mg vs placebo; 2,519 on Zepbound, 958 on placebo
- > “When stopping tirzepatide, it is highly likely your appetite will return to what you considered normal before using the drug”  
>  
> Healthline

### Gurus

Podcasts, channels, influencers

- > “While medications tend to produce greater weight loss than behavioral interventions, weight regain is more rapid once they are stopped.”  
>  
> research-review newsletter · regain about 0.4 kg per month after stopping
- > “Absolute lean mass falls, and the argument is over whether the proportion is normal for the amount of weight lost.”  
>  
> peptide-education site blog
- > “As mentioned in the podcast, these drugs do not cure obesity; the drugs must be taken for life or the weight will return.”  
>  
> independent blog post

### Regular people

Forums, reviews, comments

- > “tirzepatide has definitely had a bunch of negative side effects for me, but on the whole, it is improving my life a lot”  
>  
> Medium personal post, 6 min read
- > “After 5th injection I ended up in ED and was placed on an IV drip because I was dehydrated from the constant vomiting and diarrhea.”  
>  
> WebMD patient reviews of Mounjaro, 662 reviews, 4.1/5 overall
- > “I had similar issues on Semaglutide, but I've found Tirzepatide much more tolerable. I've lost 165lbs, A1C has gone down to 5, I have more”  
>  
> Hacker News thread (502 points, 403 comments), comment

## Questions

How do I know my Tirzepatide is genuine?

Get it on a prescription, from a pharmacy.

## The studies

Every study behind this page.

- [Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trialPubMed, PMID 34186022](https://pubmed.ncbi.nlm.nih.gov/34186022/?ref=elonmuscular.com)
- [Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesPubMed, PMID 34170647](https://pubmed.ncbi.nlm.nih.gov/34170647/?ref=elonmuscular.com)
- [Tirzepatide Once Weekly for the Treatment of ObesityPubMed, PMID 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/?ref=elonmuscular.com)
- [Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialPubMed, PMID 37385275](https://pubmed.ncbi.nlm.nih.gov/37385275/?ref=elonmuscular.com)

## Words on this page

PMID

A study's ID number in PubMed, the public index of medical research.

If you're carrying real weight, take tirzepatide and train while you're on it.

Emergency: call [911](tel:911).

I am not a doctor. This is not medical advice. This is self-education. Talk to a physician who has your history before you change anything.